Wenmiao Yu and Zhanet Zaharieva, Oxford University alumni and co-founders of Oxford spinout Quantum Dice, are not just pioneers in quantum technology but also fervent advocates for nurturing the next generation of entrepreneurs.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
The Start-up Incubator fosters entrepreneurship skills amongst the University of Oxford's students and staff.
This year, around 100,000 people in the UK will have a stroke. AI algorithms developed by Oxford University spinout Brainomix are ensuring that more of those patients will receive better care and better outcomes.
Approximately half of the spinout companies created in Oxford involve software. In response to a recent government-commissioned review calling for specific terms for ventures exclusively focused on software, OUI's Dr Richard Auburn shares his views.
Oxford University Innovation announces the much-anticipated relaunch of the Oxford Innovation Society (OIS). With an ambitious 12-month programme of events, OIS aims to fortify connections between Oxford’s companies, investors, industry partners and the vibrant Oxford entrepreneurial ecosystem.
It’s a tough climate for raising capital - our Oxford spinout companies are working hard to deliver impressive results. The OUI team recently travelled to the JPM Healthcare conference in San Francisco to connect our spinout leaders with US and global life science investors.
Oxford University Innovation Responds to the U.K. Government’s Independent Review of University Spin-Out Companies
Oxford University Innovation (OUI) welcomes the Independent Review of University Spin-out companies, published today.
Pioneering a future of informed decisions: how Prolific is shaping the next wave of research and AI training with human-centric, quality data across the globe.
For the latest in our CEO Spotlight series, we caught up with Dr Tony Coombs, Executive Chairman of Oxford VacMedix - a spinout company making waves in the world of cancer vaccines with its impressive pre-clinical and Phase 1 trial results.
The second year of the Jamies Awards deliver ideas that tackle plastic waste, drug discovery, and bad coffee.